Taobo Hu

29.7k total citations · 1 hit paper
48 papers, 422 citations indexed

About

Taobo Hu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Taobo Hu has authored 48 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Taobo Hu's work include Breast Cancer Treatment Studies (8 papers), Cancer Genomics and Diagnostics (6 papers) and AI in cancer detection (5 papers). Taobo Hu is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Cancer Genomics and Diagnostics (6 papers) and AI in cancer detection (5 papers). Taobo Hu collaborates with scholars based in China, Hong Kong and United States. Taobo Hu's co-authors include Mengping Long, Hong Xue, J. Tze‐Fei Wong, Yiqiang Liu, Shu Wang, Rolf Renne, Zhehao Dai, Guohua Lv, Yue Pan and Shi Huang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Taobo Hu

45 papers receiving 418 citations

Hit Papers

Optimizing Xenium In Situ data utility by quality assessm... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taobo Hu China 12 186 85 72 69 48 48 422
Diana Thomas United States 11 90 0.5× 100 1.2× 147 2.0× 30 0.4× 30 0.6× 24 345
Petter Ranefall Sweden 15 275 1.5× 52 0.6× 92 1.3× 35 0.5× 51 1.1× 32 665
Fei Ling China 13 305 1.6× 75 0.9× 84 1.2× 99 1.4× 35 0.7× 63 563
Jennifer Baccon United States 12 540 2.9× 110 1.3× 52 0.7× 25 0.4× 21 0.4× 26 969
Marc-Danie Nazaire United States 3 341 1.8× 71 0.8× 49 0.7× 116 1.7× 29 0.6× 3 540
Stéphane Avner France 11 500 2.7× 121 1.4× 58 0.8× 66 1.0× 33 0.7× 24 633
A. Pascual-Montano Spain 8 357 1.9× 71 0.8× 35 0.5× 92 1.3× 22 0.5× 12 539
Rafael Medina‐Flores United States 10 138 0.7× 10 0.1× 58 0.8× 36 0.5× 38 0.8× 17 376
Jonathan A. Rebhahn United States 11 199 1.1× 19 0.2× 84 1.2× 31 0.4× 11 0.2× 14 690
Chen Wf China 12 212 1.1× 65 0.8× 79 1.1× 56 0.8× 50 1.0× 38 519

Countries citing papers authored by Taobo Hu

Since Specialization
Citations

This map shows the geographic impact of Taobo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taobo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taobo Hu more than expected).

Fields of papers citing papers by Taobo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taobo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taobo Hu. The network helps show where Taobo Hu may publish in the future.

Co-authorship network of co-authors of Taobo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Taobo Hu. A scholar is included among the top collaborators of Taobo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taobo Hu. Taobo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salas, Sergio Marco, Louis B. Kuemmerle, Christophe Avenel, et al.. (2025). Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows. Nature Methods. 22(4). 813–823. 25 indexed citations breakdown →
2.
Ma, Xiao, Jie Huang, Mengping Long, et al.. (2024). CellSAM: Advancing Pathologic Image Cell Segmentation via Asymmetric Large‐Scale Vision Model Feature Distillation Aggregation Network. Microscopy Research and Technique. 88(2). 501–515. 1 indexed citations
3.
Hu, Taobo, Mengping Long, Zhaoyi Ye, et al.. (2024). MRRM: Advanced Biomarker Alignment in Multi-Staining Pathology Images via Multi-Scale Ring Rotation-Invariant Matching. IEEE Journal of Biomedical and Health Informatics. 29(2). 1189–1198. 1 indexed citations
4.
Hu, Taobo, Mengping Long, Xiao Ma, et al.. (2024). MSGM: An Advanced Deep Multi-Size Guiding Matching Network for Whole Slide Histopathology Images Addressing Staining Variation and Low Visibility Challenges. IEEE Journal of Biomedical and Health Informatics. 28(10). 1–12. 3 indexed citations
5.
Chen, Si, et al.. (2024). Forward–reverse mutation cycles in cancer cell lines under chemical treatments. Human Genomics. 18(1). 106–106. 1 indexed citations
6.
Lim, Hyeyeun, Marie‐Claude Gingras, Jing Zhao, et al.. (2024). Somatic mutations of esophageal adenocarcinoma: a comparison between Black and White patients. Scientific Reports. 14(1). 8988–8988. 1 indexed citations
7.
Mei, Liye, Mengping Long, Jin Huang, et al.. (2024). Accurately matching serial whole slide images for tumor heterogeneity analysis. Biomedical Signal Processing and Control. 100. 106825–106825.
9.
10.
Long, Mengping, et al.. (2022). Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan. International Journal of Environmental Research and Public Health. 19(18). 11531–11531. 1 indexed citations
11.
Lu, Xianzheng, Xiaojie Zhou, Jian Zhang, et al.. (2022). Tunable mechanical and degradation properties of biodegradable Mg–Y–Zn alloys via Zn content regulation. Journal of Materials Research and Technology. 20. 3173–3184. 11 indexed citations
12.
Liu, Hongjun, et al.. (2022). The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database. Annals of Translational Medicine. 10(6). 365–365. 4 indexed citations
13.
14.
Hu, Taobo, et al.. (2021). Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores. BMC Medical Research Methodology. 21(1). 108–108. 11 indexed citations
15.
Hu, Taobo, et al.. (2021). Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy. Genes & Diseases. 9(3). 659–667. 17 indexed citations
16.
Wu, Zhenggang, Xi Long, Shui Ying Tsang, et al.. (2020). Genomic subtyping of liver cancers with prognostic application. BMC Cancer. 20(1). 84–84. 6 indexed citations
17.
Hu, Taobo, et al.. (2018). AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data. Genes & Diseases. 6(1). 43–46. 9 indexed citations
18.
Hu, Taobo, et al.. (2016). Feature co-localization landscape of the human genome. Scientific Reports. 6(1). 20650–20650. 10 indexed citations
19.
Hu, Taobo, et al.. (2013). The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later. Science China Life Sciences. 56(3). 254–261. 16 indexed citations
20.
Hu, Taobo, et al.. (1999). Regulation of noncoding region for expression of Sendai virus hemagglutinin-neuraminidase (HN) gene. Science in China Series C Life Sciences. 42(4). 362–369. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026